Healthcare Executive Passes Out During Oval Office Announcement
Gordon Findlay, Healthcare Executive of Novo Nordisk, fainted Thursday at the Oval Office amid an event focused on weight loss drugs. The announcement, which involved President Donald Trump and Dr. Mehmet Oz, was temporarily paused as medical attention was given.
"During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted," said White House Press Secretary Karoline Leavitt. "The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly."
Details of the Event
The event highlighted a new deal with Eli Lilly and Novo Nordisk, allowing certain obesity drugs to be sold in the U.S. for approximately $150 per month.
- Multiple speakers addressed the attendees, including Eli Lilly CEO David Ricks.
- Findlay passed out during Ricks’ speech, prompting an immediate medical response.
- Press was asked to leave the room temporarily while medical assistance was provided.
- White House Deputy Press Secretary Kush Desai stated Dr. Kennedy left the room to assist.
- The conference resumed by 1:29 p.m.
Summary
The swift response ensured Findlay’s condition stabilized, allowing the event to continue without further incident.
Author's Note
This incident underlined the intense pressure and high stakes at the announcement of new affordable weight loss treatments.
Would you like the tone to be more formal or conversational?